Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-26

Clinical Trial Update: Study to Examine Efficacy and Safety of Rituximab in Participants With Rheumatoid Arthritis

View source ↗

Summary

A clinical trial evaluating rituximab in rheumatoid arthritis has completed and posted results in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2016-10-26